Concepedia

Matthew J. Frigault

MJ

82

Publications

9.7K

Citations

40

H-Index

2009

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Matthew J. Frigault is an author at Massachusetts General Hospital specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2009–2025

82

Publications

82

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone, Matthew J. Frigault, Naomi Serling‐Boyd et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2019 · 549 citations · Full text

CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

Bryan D. Choi, Xiaoling Yu, Ana P. Castaño et al. · Nature Biotechnology · 2019 · 539 citations

, , +9

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2020 · 470 citations · Full text

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran et al. · Blood Advances · 2020 · 421 citations · Full text

Rows per page

1–5 of 82